Last reviewed · How we verify
Sertraline and Alprazolam XR
At a glance
| Generic name | Sertraline and Alprazolam XR |
|---|---|
| Sponsor | Indiana University School of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Hydroxyzine for Patients With Panic Disorder (PHASE4)
- A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sertraline and Alprazolam XR CI brief — competitive landscape report
- Sertraline and Alprazolam XR updates RSS · CI watch RSS
- Indiana University School of Medicine portfolio CI